NO972582D0 - Anvendelse av teofyllinderivater, for behandling og profylakse av sjokktilstander, nye xantanforbindelser og deres fremstilling - Google Patents

Anvendelse av teofyllinderivater, for behandling og profylakse av sjokktilstander, nye xantanforbindelser og deres fremstilling

Info

Publication number
NO972582D0
NO972582D0 NO972582A NO972582A NO972582D0 NO 972582 D0 NO972582 D0 NO 972582D0 NO 972582 A NO972582 A NO 972582A NO 972582 A NO972582 A NO 972582A NO 972582 D0 NO972582 D0 NO 972582D0
Authority
NO
Norway
Prior art keywords
prophylaxis
preparation
treatment
new
shock conditions
Prior art date
Application number
NO972582A
Other languages
English (en)
Other versions
NO972582L (no
NO312400B1 (no
Inventor
Ulrich Gebert
Erhard Wolf
Elisabeth Defossa
Uwe Heinelt
Hiristo Anagnostopulos
Karl Rudolphi
John J Grome
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19622737A external-priority patent/DE19622737A1/de
Priority claimed from DE1996129815 external-priority patent/DE19629815A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO972582D0 publication Critical patent/NO972582D0/no
Publication of NO972582L publication Critical patent/NO972582L/no
Publication of NO312400B1 publication Critical patent/NO312400B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO19972582A 1996-06-07 1997-06-06 Anvendelse av teofyllinderivater for behandling og profylakse av sjokktilstander, nye xantanforbindelser og deres fremstilling NO312400B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19622737A DE19622737A1 (de) 1996-06-07 1996-06-07 Verwendung von Theophyllinderivaten zur Behandlung und Prophylaxe von Schockzuständen, neue Xanthinverbindungen und Verfahren zu deren Herstellung
DE1996129815 DE19629815A1 (de) 1996-07-24 1996-07-24 Verwendung von Theophyllinderivaten zur Behandlung und Prophylaxe von Schockzuständen, neue Xanthinverbindungen und Verfahren zu deren Herstellung

Publications (3)

Publication Number Publication Date
NO972582D0 true NO972582D0 (no) 1997-06-06
NO972582L NO972582L (no) 1997-12-08
NO312400B1 NO312400B1 (no) 2002-05-06

Family

ID=26026372

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19972582A NO312400B1 (no) 1996-06-07 1997-06-06 Anvendelse av teofyllinderivater for behandling og profylakse av sjokktilstander, nye xantanforbindelser og deres fremstilling

Country Status (26)

Country Link
US (1) US6214992B1 (no)
EP (1) EP0812844B1 (no)
JP (1) JP4156687B2 (no)
KR (1) KR100477177B1 (no)
CN (1) CN1066146C (no)
AR (1) AR007506A1 (no)
AT (1) ATE226583T1 (no)
AU (1) AU712277B2 (no)
BR (1) BR9703499A (no)
CA (1) CA2207120C (no)
CZ (1) CZ292205B6 (no)
DE (1) DE59708533D1 (no)
DK (1) DK0812844T3 (no)
ES (1) ES2185837T3 (no)
HU (2) HU225040B1 (no)
ID (1) ID19469A (no)
IL (1) IL120997A (no)
MX (1) MX9704203A (no)
MY (1) MY117910A (no)
NO (1) NO312400B1 (no)
NZ (1) NZ328017A (no)
PL (1) PL186576B1 (no)
PT (1) PT812844E (no)
RU (1) RU2201930C2 (no)
SI (1) SI0812844T1 (no)
TW (1) TW520285B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9703044D0 (en) * 1997-02-14 1997-04-02 Glaxo Group Ltd Phenyl xanthine esters and amides
GB9817623D0 (en) * 1998-08-13 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
FR2804867B1 (fr) * 2000-02-15 2002-09-20 Hoechst Marion Roussel Inc Application de derives de xanthine pour la preparation d'un medicament destine a la prevention ou au traitement de l'osteoporose
FR2804958B1 (fr) * 2000-02-15 2005-07-08 Hoechst Marion Roussel Inc Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant
UA80258C2 (en) * 2001-09-06 2007-09-10 Biogen Inc Methods of treating pulmonary disease
EP1509525B9 (en) * 2002-05-31 2007-10-31 Schering Corporation Process for preparing xanthine phosphodiesterase v inhibitors and precursors thereof
SI1509525T1 (sl) * 2002-05-31 2006-12-31 Schering Corp Postopek priprave inhibitorjev ksantinske fosfodiesteraze V in njihovih prekurzorjev
CN112500413B (zh) * 2020-10-13 2024-03-01 安徽中医药大学 一类黄嘌呤芳酸醚衍生物，其制备方法及用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4735898A (en) 1985-07-16 1988-04-05 The University Of Virginia Alumini Patents Foundation Monoclonal antibodies and method of identifying species using the same
US4904472A (en) * 1987-04-10 1990-02-27 The University Of Virginia Alumni Patent Foundation Use of adenosine antagonists in the treatment of bradyarrhythmias and mechanical dysfunction associated with cardiopulmonary resuscitation
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
JPH03167186A (ja) * 1989-11-24 1991-07-19 Hokuriku Seiyaku Co Ltd キサンチン誘導体及びその用途
US5036683A (en) * 1990-06-04 1991-08-06 Geuvjehizian Moushegh Y Steering wheel lock protector
DE4019571A1 (de) * 1990-06-20 1992-01-02 Hoechst Ag Pharmazeutische kombinationspraeparate enthaltend cephalosporin- und xanthinderivate und deren verwendung
DE19540798A1 (de) * 1995-11-02 1997-05-07 Hoechst Ag Alkylxanthinphosphonate und Alkylxanthinphosphinoxide und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
NZ328017A (en) 2001-05-25
MX9704203A (es) 1998-04-30
KR100477177B1 (ko) 2005-09-30
ID19469A (id) 1998-07-16
RU2201930C2 (ru) 2003-04-10
HU0500865D0 (en) 2005-11-28
KR980008230A (ko) 1998-04-30
AU712277B2 (en) 1999-11-04
HUP9701016A3 (en) 2004-11-29
ES2185837T3 (es) 2003-05-01
CA2207120A1 (en) 1997-12-07
NO972582L (no) 1997-12-08
PL320413A1 (en) 1997-12-08
IL120997A0 (en) 1997-11-20
NO312400B1 (no) 2002-05-06
HU225040B1 (en) 2006-05-29
MY117910A (en) 2004-08-30
DK0812844T3 (da) 2003-02-17
EP0812844A2 (de) 1997-12-17
JPH1059969A (ja) 1998-03-03
CN1169993A (zh) 1998-01-14
PL186576B1 (pl) 2004-01-30
SI0812844T1 (en) 2003-02-28
JP4156687B2 (ja) 2008-09-24
ATE226583T1 (de) 2002-11-15
HU224958B1 (en) 2006-04-28
BR9703499A (pt) 1998-10-06
DE59708533D1 (de) 2002-11-28
AU2469897A (en) 1997-12-11
IL120997A (en) 2001-06-14
PT812844E (pt) 2003-03-31
CA2207120C (en) 2007-05-08
EP0812844B1 (de) 2002-10-23
HU9701016D0 (en) 1997-07-28
CZ174397A3 (en) 1997-12-17
CZ292205B6 (cs) 2003-08-13
EP0812844A3 (de) 1998-04-08
HUP9701016A2 (hu) 1998-12-28
CN1066146C (zh) 2001-05-23
TW520285B (en) 2003-02-11
AR007506A1 (es) 1999-11-10
US6214992B1 (en) 2001-04-10

Similar Documents

Publication Publication Date Title
NO954942L (no) Nye erytromycinderivater, fremgangsmåte for deres fremstilling og anvendelse av derivatene som legemidler
NO20015156D0 (no) 5-pyridyl-1,3-Azol forbindelser, fremgangsmåte for produksjon av de samme og deres anvendelse
HUP0004512A3 (en) 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases
NO892083L (no) Fremgangsmaate for fremstilling av arylmetylenyl-derivaterav tiazolidinoner, imidazolidinoner og oksazolidinoner.
NO934146L (no) Nye derivater av tiopyranopyrrol, deres fremstilling og farmasoeytiske preparater inneholdende forbindelsene
MX9202290A (es) Nuevos derivados de tiopiranopirrol y procedimiento para su preparacion.
FI954718A (fi) Heterosykliset johdannaiset iskeemian ja vastaavien sairauksien hoitamiseksi
NO904921L (no) Fremgangsmaate til fremstilling av modifiserte gangliosider og deres funksjonelle derivater.
NO20000294D0 (no) Derivater av acylpiperazinylpyrimidiner, deres fremstilling og anvendelse som legemidler
NO943682D0 (no) Imidazol-4-yl-piperidin-derivater, deres fremstilling og terapeutiske anvendelse
NO20022021D0 (no) Indeno-, nafto- og benzocyklohepta-dihydrotiazolderivater, fremstilling av de samme og deres anvendelse somanoreksilegemidler
NO922426L (no) Forbindelser med reninhemmende egenskaper, fremgangsmaate for fremstilling av disse og deres anvendelse
NO304384B1 (no) Al-Sr-Si-B-forlegering, fremgangsmÕte for dens fremstilling og anvendelse av forlegeringen
NO943794L (no) 4-difenylmethylpiperidinderivater, og fremgangsmåte for deres fremstilling
IS3951A (is) Cephalosporinafleiður, aðferð til framleiðslu þeirra og notkunar sem lyfja
NO972582D0 (no) Anvendelse av teofyllinderivater, for behandling og profylakse av sjokktilstander, nye xantanforbindelser og deres fremstilling
NO900643D0 (no) Fremgangsmaate for fremstilling og anvendelse av 2,3,23-trihydroksi-urs-12-ener og deres derivater.
NO940130D0 (no) Benzimidazolderivater, fremgangsmaate for deres fremstilling og te rapeutisk anvendelse derav
NO984624L (no) Nye furan-diarylmetyliden-derivater, fremgangsmÕte for deres fremstilling og terapeutiske anvendelser derav
NO921563L (no) Terapeutisk aktive aminopyrimidinderivater, fremgangsmaatefor deres fremstilling og anvendelse derav
NO20012541D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
NO971424D0 (no) Nye heterocyklisk substituerte imidazolo-kinoksalidoner, deres fremstilling og anvendelse
NO922428D0 (no) Heterocykliske forbindelser med reninhemmende egenskaper,deres fremstilling og anvendelse
DK0763535T3 (da) Piperidinylmethyloxazolidin-2-on-derivater, deres fremstilling og deres anvendelse som centralnervesystem-aktive forbindelser
NO921908D0 (no) Aminosyreazetidinylsubstituerte pyridonderivater, deres fremstilling og anvendelse som medikamenter

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees